Who Paid My Doc
Jason Davis
Diagnostic Ultrasound Normal, IL Medical Doctor
NPI 1982639621 CMS profile 270892
2200 Fort Jesse Rd, Normal, IL 61761
General payments
$113
Research payments
$0
Ownership & investment interest
$0
Through program year 2023, Jason Davis of Normal, IL is reported in the CMS Open Payments database as having received $113 across 2 general payments and $0 in research payments paid to them.
No combined total General, research and ownership are kept apart. Each is reported under its own rules, and ownership is not money that moved at all but the value of a stake held. A meal, a clinical trial grant and a shareholding do not add up to anything meaningful, so this site does not add them.
By program year
2 rows| Year | Kind | Relative to this record's peak year | Amount | Records |
|---|---|---|---|---|
| 2023 | General | $93 | 1 | |
| 2022 | General | $20 | 1 |
Beside peers
- Jason Davis
- Diagnostic Ultrasound median
- Middle half of Diagnostic Ultrasound
- National median
In program year 2025, general payments to Jason Davis were reported at $0. Among 21 Diagnostic Ultrasound profiles paid that year, the median was $96 and the middle half received between $28 and $176.
Show as a table
| Year | Jason Davis | Diagnostic Ultrasound median | Middle half | National median |
|---|---|---|---|---|
| 2019 | $0 | $62 | $16–$172 | $163 |
| 2020 | $0 | — | — | $114 |
| 2021 | $0 | $58 | $16–$248 | $132 |
| 2022 | $20 | $92 | $24–$166 | $149 |
| 2023 | $93 | $65 | $20–$123 | $160 |
| 2024 | $0 | $91 | $24–$274 | $164 |
| 2025 | $0 | $96 | $28–$176 | $169 |
Breakdown
A payment can name more than one product, so these amounts overlap and do not add up to the general-payment figure.
Billing to Medicare
Part B · data year 2024 · 143 billing codesPaid by Medicare
$379,214
Medicare patients
2,151
Services billed
17,973
| Condition among their Medicare patients | Relative to the most common | Share of patients |
|---|---|---|
| High blood pressure | 68% | |
| Arthritis | 52% | |
| Diabetes | 24% | |
| Ischemic heart disease | 24% | |
| Chronic kidney disease | 22% | |
| Depression | 22% | |
| Osteoporosis | 19% | |
| Cancer | 18% |
| Drug given in the clinic | Where | Patients | Services | Paid by Medicare |
|---|---|---|---|---|
| Injection, gadobenate dimeglumine (multihance), per ml A9577 | Office | 94 | 1,450 | $2,079 |
| Low osmolar contrast material, 300-399 mg/ml iodine concentration, per ml Q9967 | Office | 120 | 12,396 | $1,268 |
Medicare Part B only: services billed to Medicare. Rows covering fewer than 11 beneficiaries are not published. Only drugs given in the clinic are itemised here; the rest of what this provider billed is in the total above.
Records
2 reportedEvery payment, record by record
Date, company, amount, what it was for and the product named — filter by year, kind and company, or download as CSV.
Other Diagnostic Ultrasound in Illinois
David Kimball
Diagnostic Ultrasound · Urbana, IL
Juan Jimenez
Diagnostic Ultrasound · Urbana, IL
John Bochniak
Diagnostic Ultrasound · Hoffman Estates, IL
Sharmi Jayachandran
Diagnostic Ultrasound · Geneva, IL
Luis Garcia
Diagnostic Ultrasound · Skokie, IL
Shilpa Mehta
Diagnostic Ultrasound · Hoffman Estates, IL
Related records
Diagnostic Ultrasound in Illinois
Practitioners in the same specialty and state, ranked by reported value.
All Diagnostic Ultrasound
Everyone recorded under this specialty, nationwide.
Doctors in Illinois
Every practitioner in the state with a reported payment.
How to read this page
What each amount means, and what it does not mean.
What this means
U.S. law requires drug and medical device manufacturers to report payments and transfers of value they make to physicians and teaching hospitals. The Centers for Medicare & Medicaid Services publishes that record each year. This page shows what was reported about this person, and nothing else.
An ownership interest is different from the other two. It is not a payment: it is a stake — shares, options, a partnership holding — that a physician or an immediate family member held in a manufacturer during that year. The figure shown is what the stake was reported to be worth.
Research payments frequently pass through a clinician to the institution running a trial, and rarely represent personal income. They should be read differently from general payments.